Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

B-Temia and Wistron Announce the Incorporation of B-Temia Asia

B-Temia Asia Will Launch Human Mobility Device Keeogo(TM) in the Asia Market

B-Temia Inc. announced the official incorporation of B-Temia Asia Pte. Ltd., as a result of their joint venture agreement with Wistron Corporation in June 2018, to launch its innovative Dermoskeleton technology Keeogo in Asia. B-Temia is a Canadian robotics tech company and leader in the human mobility market, and Wistron is one of the world’s largest original design manufacturer (ODM) with revenues over CA$36 billion and a major shareholder in B-Temia. Over the last year, both organizations have efficiently demonstrated their ability to work together as manufacturing was seamlessly transitioned to Asia.

Read More: Sixgill Backstops Security with Blockchain Data Integrity for IoE Applications

B-Temia Asia, based in Singapore, will immediately start to commercialize Keeogo in several countries in Asia such as China, Japan and Australia. Recently, Keeogo  was showcased in China at the Care & Rehabilitation Expo, the largest event of its kind in China, held from October 11th to the 13th in Beijing. More than one hundred people, including experts, key opinion leaders and patients had the opportunity to wear and experience KeeogoTM during the event. It was an overwhelming success.

Related Posts
1 of 308

Read More: Arthur D. Little Predicts Transformative Changes in Commercial Aviation Market by 2035

“B-Temia Asia represents a concrete realization of our mission to help people throughout the world regain their autonomy through mobility” stated Mr. Stephane Bedard, CEO. “The Corporation is now expanding into multiple international markets and we envision our Dermoskeleton technology being used by clinicians and individuals around the world over the next three years” added Mr. Bedard; “Thanks to Wistron and our shareholders for joining us in a shared vision to deliver the benefits of KeeogoTM to the global market and grow B-Temia’s operations”. “B-Temia Asia is another demonstration of the real value of our technology and the need to bring life-changing, modern solutions to the many people living with mobility limitations”; “It is another very exciting time for our shareholders”, concluded Mr. Bedard.

Read More: Atlas Protocol Joins IAB Tech Lab Blockchain Working Group

“The incorporation of B-Temia Asia marks the start of our official operation in Asia to market this highly beneficial technology for people with mobility challenges. There are a few Asian countries that are at the top of the aging population list, and the elderly may also need mobility assistance. KeeogoTM will have an immediate impact on our goal to help improve people’s lives,’ said Donald Hwang, CTO of Wistron Corporation.

Read More: Fastly’s Global Momentum Continues as Today’s Most Important Brands Adopt Edge Computing at Scale

Leave A Reply

Your email address will not be published.